Category Archives: Medtonic Infuse

Featured Stories
Fracking Releasing Hazardous Chemicals into Local Waterways

Fracking Releasing Hazardous Chemicals into Local Waterways

Study shows two hazardous chemicals—ammonium & iodide—are being released & spilled into Pennsylvania and W.Virginia waterways from fracking operations in Marcellus shale.

Read More

Knee Replacement Patients Should Consider Nickel Allergies before Surgery

Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...

Read More

Scientist Calls for Federal Regulations for Fracking Pollution

Hydraulic fracturing (fracking) drilling should be governed by federal regulations because its pollution has no awareness of state boundaries.

Read More

Newly-Filed Plavix Lawsuits Claim Drug Caused Gastrointestinal Bleeds, Cerebral Hemorrhage, and TTP

The manufacturer of Plavix continues to be named in lawsuits alleging the blood thinner caused some patients to suffer from serious bleeding side effects. Most recently, the national law firm of Parker Waichman LLP filed nine Plavix bleeding lawsuits in state court in New York.

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two-Leading-Cancer-Groups-Issue-Call-for-Regulation-of-E-cigarettes-and-Research-on-Health-Risks

The American Society of Clinical Oncology & the American Association for Cancer Research called for government regulation & research of e-cigarettes on health effects.

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...

Read More

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

Regulators in the U.K. are once again issuing advice to doctors and other healthcare professionals involved in the follow-up of patients with metal-on-metal hip replacement devices. In an alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA), guidance is provided for four groups of metal-on-metal hip implant ...

Read More

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

Medtronic Infuse Recipients Receive $8.45 Million in Settlements

Medtronic Infuse Recipients Win $8.45 Million in Settlements

The University of California, Los Angeles has agreed to pay a combined $8.45 million to two patients who received Medtronic’s controversial Infuse bone graft product. These individuals filed lawsuits alleging that the product caused unwanted bone growth. They also claimed … Continue reading

Posted in Defective Medical Devices, Legal News, Medtonic Infuse | Tagged , , , , , , , , , , |

Medtronic Pays $500 Million Tax Charge To Move $9.8 Billion To United States

Medtronic Pays $500M Tax Charge To Move $9.8B To U.S.

As part of an internal restructuring related to its $49.9 billion merger with Covidien, Medtronic will pay a one-time tax charge of $500 million so that it can bring $9.8 billion in overseas cash to the United States. This move … Continue reading

Posted in Defective Medical Devices, Legal News, Medtonic Infuse | Tagged , , , , |

European Regulators Review Medtronic’s InductOs in Light of Contamination Issues

European Regulators Review Medtronic’s InductOs

The European Medicines Agency (EMA) will be reviewing Medtronic’s InductOs following reports of contamination problems at a site that manufacturers one of the product’s components. InductOs is an implantable bone development product used in patients undergoing spinal fusion in the … Continue reading

Posted in Legal News, Medtonic Infuse | Tagged , , , |

Federal Data Shows Medtronic Continues to Pay Doctors in Connection with InFuse Spinal Fusion Device

Federal Data Shows Medtronic Continues to Pay Doctors

Data available through the federal Open Payments database show that device maker Medtronic continues to pay millions of dollars to doctors whose research on the InFuse spinal fusion device has been called into question. Medtronic’s spine division, Medtronic Sofamor Danek, … Continue reading

Posted in Defective Medical Devices, Health Concerns, Medtonic Infuse | Tagged , , , , |

Study Reports Decline in Use of Bone Morphogenetic Proteins in Spinal Surgeries

Decline in Use of Bone Morphogenetic Proteins in Surgeries

Bone morphogenetic proteins (BMPs) have been widely used in spinal fusion surgeries since their approval in 2002, a new study published in the journal Spine says BMP use has declined in response to concerns about safety and complications. After BMP … Continue reading

Posted in Defective Medical Devices, Health Concerns, Medtonic Infuse | Tagged , , , |

Lawsuit Involving Medtronic’s InFuse Bone Graft Product Filed in St. Louis

Medtronic’s InFuse Bone Graft Product Filed in St. Louis

A group of law firms has filed a lawsuit in Circuit Court in St. Louis against Medtronic, Inc. on behalf of patients who allege injuries that include catastrophic, unchecked bone growth in the spinal column following surgical procedures with Medtronic’s … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse |

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA Warning for Bone Graft Products in Patients Under 18

The Food and Drug Administration has issued a safety alert to healthcare providers, patients, and parents and guardians that bone graft devices containing recombinant proteins or synthetic peptides should not be the first treatment considered for patients under age 18. … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse | Tagged , , , , |

Medtronic Denied Preemption in Another Device Injury Lawsuit

medtronic_denied_preemption

An Indiana appeals court just ruled that Medtronic cannot use so-called “preemption” to get out of a negligence lawsuit filed over a failed Transvene defibrillator lead. Preemption is legal concept that a number of medical device makers have used in … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Defibrillators, Medtronic Infuse |

Lawsuit Filed Against Medtronic for Promoting Off-Label Use of Infuse

medtronic_infuse_lawsuit_filed

A lawsuit filed this week alleges that Medtronic Inc. deliberately promoted the off-label use of its Infuse bone graft product. The complaint includes the names of 98 plaintiffs who allege that the off-label use of Medtronic caused them to incur … Continue reading

Posted in Medtonic Infuse |

Medtronic Issued Warning Letter Over Its Diabetes Facility

medtronic_diabetes_FDA_warning

Device maker, Medtronic Inc., was just issued a warning letter from the U.S. Food and Drug Administration (FDA) concerning its Northridge, California diabetes facility. The letter was received on September 19 and discussed procedures involving “corrective and preventative action, complaint … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.